Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.19 USD
Change Today -0.44 / -3.01%
Volume 397.3K
KPTI On Other Exchanges
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sharon Shacham Ph.D., MBA

Co-Founder, Co-Chairman of Scientific Advisory Board, President and Chief Scientific Officer,Karyopharm Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Sharon Shacham, Ph.D., MBA Co-Founded Karyopharm Therapeutics, Inc., in 2008 and has been its Chief Scientific Officer and President since October 2010 and since December 2013 Respectively. Dr. Shacham served as the President of Research & Development at Karyopharm Therapeutics, Inc. since December 2012. until December 2013. She served as President and Chief Executive Officer of Karyopharm Therapeutics, Inc. from October 2010 to January 2011 and its Chief Scientific ...

Read Full Background

Corporate Headquarters*

85 Wells Avenue
Newton, Massachusetts 02459

United States

Phone: 617-658-0600
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


Tel Aviv University
Tel Aviv University
Tel Aviv University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$385,000

Stock Options*

All Other Compensation$10,820
Exercisable Options367,858
Exercisable Options Value$12,211,244
Unexercisable Options456,422
Unexercisable Options Value$13,025,567
Total Value of Options$25,236,811
Total Number of Options824,280

Total Compensation*

Total Annual Cash Compensation$534,320
Total Short Term Compensation$385,000
Other Long Term Compensation$10,820
Total Calculated Compensation$534,320
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KPTI:US $14.19 USD -0.44


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KARYOPHARM THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at